What does CUSIP 12648L601 represent in this 13F holders report?

CUSIP 12648L601 is the security identifier for CTIC - CTI BIOPHARMA CORP - COM used to aggregate holder disclosures.

How many institutions held CTIC - CTI BIOPHARMA CORP - COM in Q2 2020?

31 institutional investors reported CTIC - CTI BIOPHARMA CORP - COM for Q2 2020. Use the holders table for investor-level position and value details.

CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L601

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / COM
Total 13F shares: 34,459,341
Share change: -2,159,418
Total reported value: $39,971,290
Price per share: $1.16
Number of holders: 31
Value change: -$2,495,859
Number of buys: 12
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 12648L601?
CUSIP 12648L601 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q2 2020

As of 30 Jun 2020, CTI BIOPHARMA CORP - COM (CTIC) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,459,341 shares. The largest 10 holders included ORBIMED ADVISORS LLC, NEA Management Company, LLC, BVF INC/IL, Stonepine Capital Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CAXTON CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 31 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.